
Akanocure: Focused on developing drugs for orphan and unmet oncology needs.
Akanocure Pharmaceuticals, founded in West Lafayette, IN, is dedicated to addressing orphan and unmet needs in oncology through innovative drug development. The company's core mission is to design novel small molecules that can significantly improve the lives of cancer patients. Utilizing an advanced chemistry platform, Akanocure focuses on the entire drug discovery and development process to create effective treatments for rare and underserved cancer types.
Notable figures affiliated with Akanocure include experts in drug design and oncology research, although specific names are not provided. The company has made significant strides in developing promising oncology drugs, contributing to the broader field of cancer treatment. Akanocure's impact lies in its commitment to addressing critical gaps in cancer therapy, offering hope for patients with limited treatment options.

Alcinous Pharmaceuticals

NiKang Therapeutics

OnKure Therapeutics

NextCure
nextcure.com

Novita Pharmaceuticals
novita-pharm.com

Onkaido Therapeutics

Onchilles Pharma

Curelab Oncology

Accuitis
accuitis.com

Traws Pharma

Panacela Labs
panacelalabs.com

BioNumerik Pharmaceuticals

Anew Oncology

Advanced Cancer Therapeutics

Advenchen Laboratories
advenchen.com
Companies similar to Akanocure Pharmaceuticals include Alcinous Pharmaceuticals, NiKang Therapeutics, OnKure Therapeutics and NextCure.
Akanocure Pharmaceuticals was founded in 2015.
Akanocure Pharmaceuticals' headquarters is located in West Lafayette, IN, US.
Akanocure Pharmaceuticals' most recent funding round was for $5k (USD) in August 2022.
As of Aug 10, 2022, Akanocure Pharmaceuticals has raised a total of $2M (USD).
Akanocure Pharmaceuticals has 9 employees as of Feb 5, 2024.